Epitranscriptomics in Cancers (EpiCancer) is a curated knowledgebase of functional regulation factors, targeted drugs, and multi-dimensional regulation information of both m6A regulators and m6A sites in cancers.

Home upstream downstream drug publication regulators sites cancers

News and Update

  • New features of EpiCancer are under development. (Jul 2, 2021)
  • EpiCancer version 1.0 is publicly accessible. (Jun 26, 2021)

Please cite

  • Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2021. Nucleic Acids Res. 2021. [PMID=33175170]

To get the best experience, please visit us using the latest version of Google Chrome, Firefox, Safari, Opera or Internet Explorer 10 and above.